asco23 - lba5507: phase iii mirasol (gog 3045/engot-ov55) study (ovarian cancer)
Published 1 year ago • 308 plays • Length 12:52Download video MP4
Download video MP3
Similar videos
-
4:40
asco 2023 highlights on the mirasol trial in pt-resistant adv. high-grade epithelial ovarian cancer
-
7:31
asco 2024 - lba5505 - the caraco phase iii randomized trial
-
3:42
gynecologic oncology at asco 2022: athena–mono trial (rucaparib monotherapy) for ovarian cancer
-
4:06
clinical data from the phase iii prima trial
-
3:11
ovarian cancer phase iii trial updates: imagyn050 and icon8
-
0:48
my shocking symptom of ovarian cancer
-
1:35
dr. mirza on the phase iii nova trial in ovarian cancer
-
0:42
ovarian cancer staging
-
0:59
genitourinary cancer updates at asco 2023
-
2:19
dr. moore on anticipated impact of the mirasol trial in platinum-resistant ovarian cancer
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
0:25
some most commonly asked questions about ovarian cancer
-
0:52
what educational resources are available through the ovarian cancer research fund part 2 #sharecare
-
3:47
looking forward to asco: updates in ovarian cancer
-
4:53
dr robb hollis: ‘towards new therapies for low grade serous ovarian cancer.’
-
5:06
asco22 gynecologic oncology: relacorilant combined with nab-paclitaxel in recurrent ovarian cancer
-
27:39
novel therapeutics in ovarian cancer: what to watch
-
1:50
niraparib as maintenance for platinum-sensitive ovarian cancer - results from engot-ov16/nova trial